Clinical Trial

Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)

Name: Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA) — clinical trial record (NCT07265570)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and clinical efficacy of ISM5411 in adult patients with active ulcerative colitis.

Protocol Amendment History 1 change

notable Trial sites expanded: 24 -> 28 locations 2026-04-01

Trial Details

NCT Number	NCT07265570
Lead Sponsor	InSilico Medicine Hong Kong Limited
Conditions	Ulcerative Colitis
Enrollment	80 participants
Start Date	2025-12-10
Primary Completion	2027-08-15 (estimated)
Study Completion	2027-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-01